3-D Matrix, Ltd. (TYO:7777)
230.00
-14.00 (-5.74%)
Aug 12, 2025, 3:30 PM JST
3-D Matrix Revenue
In the fiscal year ending April 30, 2025, 3-D Matrix had annual revenue of 6.93B JPY with 51.13% growth. 3-D Matrix had revenue of 1.88B in the quarter ending April 30, 2025, with 16.90% growth.
Revenue
6.93B
Revenue Growth
+51.13%
P/S Ratio
3.72
Revenue / Employee
60.82M
Employees
114
Market Cap
25.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2025 | 6.93B | 2.35B | 51.13% |
Apr 30, 2024 | 4.59B | 2.27B | 98.27% |
Apr 30, 2023 | 2.31B | 808.00M | 53.65% |
Apr 30, 2022 | 1.51B | 482.00M | 47.07% |
Apr 30, 2021 | 1.02B | 352.00M | 52.38% |
Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |